Surgical Suture Polyglactine 75cm, USP 4/0, 3/8 Circle Reverse Cutting (RC) 19mm Needle

Surgical suture made of absorbable Polyglactine 910 is designed for general soft tissue approximation and/or ligation, providing high tensile strength and a predictable absorption profile. The braided and coated multifilament structure ensures reliable handling and minimal tissue reaction. The product is supplied in USP 4/0 size, 75 cm length, with a 3/8 circle reverse cutting (RC) 19 mm needle.

This synthetic absorbable suture is composed of Polyglactine 910, a copolymer consisting of 90% glycolide and 10% L-lactide, coated with poly(glycolide-co-L-lactide) and calcium stearate (<1%). The material is degraded by hydrolysis, resulting in complete absorption between 56 and 70 days. Approximately 50% of the initial tensile strength remains after 21 days. Each box contains 12 sterile sutures in hermetically sealed packaging.

Features and Specifications:
• Synthetic absorbable surgical suture
• Composition: Polyglactine 910 (90% glycolide, 10% L-lactide)
• Coating: poly(glycolide-co-L-lactide) and calcium stearate (<1%)
• Braided and coated multifilament structure
• Suture length: 75 cm
• Size: USP 4/0
• Color: violet
• Needle: 3/8 circle reverse cutting (RC), 19 mm
• High tensile strength
• Approximately 50% tensile strength at 21 days
• Complete absorption between 56 and 70 days via hydrolysis
• Minimal tissue reaction
• Reduced capillary action
• Excellent handling properties
• High flexibility
• Excellent knot security and adjustability
• Smooth tissue passage with minimal cutting, tissue drag, and trauma
• Hermetically sealed sterile packaging

Indicated for surgical sutures in soft tissue closure and/or ligation, particularly in general surgery, skin closure, gastrointestinal surgery, plastic surgery, ophthalmic surgery, gynecology, obstetrics, orthopedics, and urology. Contraindicated in cardiovascular surgery and neurosurgery. As an absorbable suture, it should not be used where extended wound support is required. Caution is advised in patients with delayed wound healing, including those with compromised immune systems.